Medindia

X

Anti-cholinesterase drugs for treating Alzheimer's not worth the price

by Medindia Content Team on  January 22, 2006 at 1:18 PM Drug News   - G J E 4
Anti-cholinesterase drugs for treating Alzheimer's not worth the price
The National Institute for Health and Clinical Excellence (NICE) has found that anti-cholinesterase drugs which are used in the treatment of Alzheimer's disease is not very effective in controlling the disease as the cost of the drug is very high and they have reported that the drug action is not worth its cost.
Advertisement

Alzheimer's disease affects the brain tissues after one reaches forty years. Once affected, Alzheimer's gradually destroys the ability to reason, remember, imagine and learn. It is marked by abnormal clumps (plaques) and irregular knots (neurofibrillary tangles) of brain cells. For reasons not well understood, these plaques and tangles take over healthy brain tissues, devastating the areas of the brain associated with intellectual function.

Advertisement
Though NICE has not recommended that the pills are useless but speculate they can help in reducing the disease but not completely cure Alzheimer's disease and the cost of the drug is very high. Anti-cholinesterase drugs are produced by the manufacturers Pfizer Inc, Eisai Co., Johnson & Johnson, Shrine Pharmaceuticals, Novartis and Lundbeck Pharmaceutical industries.

Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
well..this is in contradiction with what NICE will say Monday... http://observer.guardian.co.uk/uk_news/story/0,,1692309,00.html don't spread lies.
guest Sunday, January 22, 2006

You May Also Like

Advertisement
View All